遺伝子治療の世界市場:ベクター種類別(ウイルスベクター、非ウイルスベクター)、遺伝子種類別(抗原、サイトカイン、腫瘍抑制因子、自殺、欠乏、成長因子、受容体、その他)、用途別(腫瘍性疾患、希少疾患、心血管疾患、神経疾患、感染症、その他)...市場調査レポートについてご紹介

【英文タイトル】Gene Therapy Market by Vector Type (Viral Vector and Non-viral Vector), Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors, and Others), and Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Other Diseases): Global Opportunity Analysis and Industry Forecast, 2019–2026



▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Chapter 1: Introduction

1.1. Report Description
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology

1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary

2.1. Cxo Perspective

Chapter 3: Market Overview

3.1. Market Definition And Scope
3.2. Key Findings

3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies

3.3. Top Player Positioning, 2018
3.4. Porter’S Five Forces Analysis
3.5. Market Dynamics

3.5.1. Drivers

3.5.1.1. High Investment For R&D Activities Pertaining To Gene Therapy
3.5.1.2. Increase In Prevalence of Cancer
3.5.1.3. Growth In Awareness Regarding Gene Therapy

3.5.2. Restraints

3.5.2.1. High Cost Associated With Gene Therapies
3.5.2.2. Unwanted Immune Responses

3.5.3. Opportunities

3.5.3.1. Untapped Potential For Emerging Markets

Chapter 4: Gene Therapy Market, By Vector Type

4.1. Overview

4.1.1. Market Size And Forecast

4.2. Viral Vectors

4.2.1. Key Market Trends, Growth Factors, And Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Size And Forecast, By Type
4.2.4. Market Size And Forecast, By Country
4.2.5. Adenovirus
4.2.6. Lentivirus
4.2.7. Retrovirus
4.2.8. Adeno-Associated Virus
4.2.9. Herpes Simplex Virus
4.2.10. Poxvirus
4.2.11. Vaccinia Virus
4.2.12. Others

4.3. Non-Viral Techniques

4.3.1. Key Market Trends, Growth Factors, And Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Size And Forecast, By Type
4.3.4. Market Size And Forecast, By Country
4.3.5. Naked Plasmid Vector
4.3.6. Gene Gun
4.3.7. Electroporation
4.3.8. Lipofection
4.3.9. Others

Chapter 5: Gene Therapy Market, By Gene Type

5.1. Overview

5.1.1. Market Size And Forecast, Type

5.2. Antigen

5.2.1. Market Size And Forecast
5.2.2. Market Size And Forecast, By Country

5.3. Cytokine

5.3.1. Market Size And Forecast
5.3.2. Market Size And Forecast, By Country

5.4. Tumor Suppressor

5.4.1. Market Size And Forecast, By Region
5.4.2. Market Size And Forecast, By Country

5.5. Suicide Gene

5.5.1. Market Size And Forecast
5.5.2. Market Size And Forecast, By Country

5.6. Deficiency

5.6.1. Market Size And Forecast, By Region
5.6.2. Market Size And Forecast, By Country

5.7. Growth Factors

5.7.1. Market Size And Forecast, By Region
5.7.2. Market Size And Forecast, By Country

5.8. Receptors

5.8.1. Market Size And Forecast, By Region
5.8.2. Market Size And Forecast, By Country

5.9. Others

5.9.1. Market Size And Forecast, By Region
5.9.2. Market Size And Forecast, By Country

Chapter 6: Gene Therapy Market, By Application

6.1. Overview

6.1.1. Market Size And Forecast, By Application

6.2. Oncological Disorders

6.2.1. Market Size And Forecast, By Region
6.2.2. Market Size And Forecast, By Country

6.3. Rare Diseases

6.3.1. Market Size And Forecast, By Region
6.3.2. Market Size And Forecast, By Country

6.4. Cardiovascular Diseases

6.4.1. Market Size And Forecast, By Region
6.4.2. Market Size And Forecast, By Country

6.5. Neurological Disorders

6.5.1. Market Size And Forecast
6.5.2. Market Size And Forecast, By Country

6.6. Infectious Diseases

6.6.1. Market Size And Forecast, By Region
6.6.2. Market Size And Forecast, By Country

6.7. Other Diseases

6.7.1. Market Size And Forecast
6.7.2. Market Size And Forecast, By Country

Chapter 7: Gene Therapy Market, By Region

7.1. Overview

7.1.1. Market Size And Forecast

7.2. North America

7.2.1. Key Market Trends, Growth Factors, And Opportunities
7.2.2. Market Size And Forecast, By Country
7.2.3. Market Size And Forecast, By Vector Type
7.2.4. Market Size And Forecast, By Gene Type
7.2.5. Market Size And Forecast, By Application

7.2.5.1. U.S. Market Size And Forecast, By Vector Type
7.2.5.2. U.S. Market Size And Forecast, By Gene Type
7.2.5.3. U.S. Market Size And Forecast, By Application
7.2.5.4. Canada Market Size And Forecast, By Vector Type
7.2.5.5. Canada Market Size And Forecast, By Gene Type
7.2.5.6. Canada Market Size And Forecast, By Application
7.2.5.7. Mexico Market Size And Forecast, By Vector Type
7.2.5.8. Mexico Market Size And Forecast, By Gene Type
7.2.5.9. Mexico Market Size And Forecast, By Application

7.3. Europe

7.3.1. Key Market Trends, Growth Factors, And Opportunities
7.3.2. Market Size And Forecast, By Country
7.3.3. Market Size And Forecast, By Vector Type
7.3.4. Market Size And Forecast, By Gene Type
7.3.5. Market Size And Forecast, By Application

7.3.5.1. Germany Market Size And Forecast, By Vector Type
7.3.5.2. Germany Market Size And Forecast, By Gene Type
7.3.5.3. Germany Market Size And Forecast, By Application
7.3.5.4. France Market Size And Forecast, By Vector Type
7.3.5.5. France Market Size And Forecast, By Gene Type
7.3.5.6. France Market Size And Forecast, By Application
7.3.5.7. Uk Market Size And Forecast, By Vector Type
7.3.5.8. Uk Market Size And Forecast, By Gene Type
7.3.5.9. Uk Market Size And Forecast, By Application
7.3.5.10. Italy Market Size And Forecast, By Vector Type
7.3.5.11. Italy Market Size And Forecast, By Gene Type
7.3.5.12. Italy Market Size And Forecast, By Application
7.3.5.13. Spain Market Size And Forecast, By Vector Type
7.3.5.14. Spain Market Size And Forecast, By Gene Type
7.3.5.15. Spain Market Size And Forecast, By Application
7.3.5.16. Rest of Europe Market Size And Forecast, By Vector Type
7.3.5.17. Rest of Europe Market Size And Forecast, By Gene Type
7.3.5.18. Rest of Europe Market Size And Forecast, By Application

7.4. Asia-Pacific

7.4.1. Key Market Trends, Growth Factors, And Opportunities
7.4.2. Market Size And Forecast, By Country
7.4.3. Market Size And Forecast, By Vector Type
7.4.4. Market Size And Forecast, By Gene Type
7.4.5. Market Size And Forecast, By Application

7.4.5.1. Japan Market Size And Forecast, By Vector Type
7.4.5.2. Japan Market Size And Forecast, By Gene Type
7.4.5.3. Japan Market Size And Forecast, By Application
7.4.5.4. China Market Size And Forecast, By Vector Type
7.4.5.5. China Market Size And Forecast, By Gene Type
7.4.5.6. China Market Size And Forecast, By Application
7.4.5.7. India Market Size And Forecast, By Vector Type
7.4.5.8. India Market Size And Forecast, By Gene Type
7.4.5.9. India Market Size And Forecast, By Application
7.4.5.10. South Korea Market Size And Forecast, By Vector Type
7.4.5.11. South Korea Market Size And Forecast, By Gene Type
7.4.5.12. South Korea Market Size And Forecast, By Application
7.4.5.13. Rest of Asia-Pacific Market Size And Forecast, By Vector Type
7.4.5.14. Rest of Asia-Pacific Market Size And Forecast, By Gene Type
7.4.5.15. Rest of Asia-Pacific Market Size And Forecast, By Application

7.5. Lamea

7.5.1. Key Market Trends, Growth Factors, And Opportunities
7.5.2. Market Size And Forecast, By Country
7.5.3. Market Size And Forecast, By Vector Type
7.5.4. Market Size And Forecast, By Gene Type
7.5.5. Market Size And Forecast, By Application

7.5.5.1. Brazil Market Size And Forecast, By Vector Type
7.5.5.2. Brazil Market Size And Forecast, By Gene Type
7.5.5.3. Brazil Market Size And Forecast, By Application
7.5.5.4. South Africa Market Size And Forecast, By Vector Type
7.5.5.5. South Africa Market Size And Forecast, By Gene Type
7.5.5.6. South Africa Market Size And Forecast, By Application
7.5.5.7. Rest of Lamea Market Size And Forecast, By Vector Type
7.5.5.8. Rest of Lamea Market Size And Forecast, By Gene Type
7.5.5.9. Rest of Lamea Market Size And Forecast, By Application

Chapter 8: Company Profile

8.1. Adaptimmune Therapeutics Plc.

8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Business Performance
8.1.6. Key Strategic Moves And Developments

8.2. Anchiano Therapeutics Ltd.

8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio

8.3. Achieve Life Sciences, Inc.

8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.3.5. Key Strategic Moves And Developments

8.4. Adverum Biotechnologies, Inc.

8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.4.5. Key Strategic Moves And Developments

8.5. Abeona Therapeutics Inc.

8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Product Portfolio
8.5.5. Business Performance
8.5.6. Key Strategic Moves And Developments

8.6. Applied Genetic Technologies Corporation

8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.6.5. Business Performance
8.6.6. Key Strategic Moves And Developments

8.7. Arbutus Biopharma Corporation

8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Product Portfolio
8.7.4. Business Performance
8.7.5. Key Strategic Moves And Developments

8.8. Audentes Therapeutics Inc.

8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Product Portfolio
8.8.4. Key Strategic Moves And Developments

8.9. Avexis Inc.

8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Product Portfolio
8.9.4. Key Strategic Moves And Developments

8.10. Bluebird Bio, Inc.

8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance
8.10.6. Key Strategic Moves And Developments

8.11. Celgene Corporation

8.11.1. Company Overview
8.11.2. Company Snapshot
8.11.3. Operating Business Segments
8.11.4. Product Portfolio
8.11.5. Business Performance
8.11.6. Key Strategic Moves And Developments

8.12. Crispr Therapeutics Ag

8.12.1. Company Overview
8.12.2. Company Snapshot
8.12.3. Product Portfolio
8.12.4. Business Performance
8.12.5. Key Strategic Moves And Developments

8.13. Editas Medicine, Inc.

8.13.1. Company Overview
8.13.2. Company Snapshot
8.13.3. Operating Business Segments
8.13.4. Product Portfolio
8.13.5. Business Performance
8.13.6. Key Strategic Moves And Developments

8.14. Gilead Sciences, Inc.

8.14.1. Company Overview
8.14.2. Company Snapshot
8.14.3. Operating Business Segments
8.14.4. Product Portfolio
8.14.5. Business Performance
8.14.6. Key Strategic Moves And Developments

8.15. Glaxosmithkline Plc

8.15.1. Company Overview
8.15.2. Company Snapshot
8.15.3. Operating Business Segments
8.15.4. Product Portfolio
8.15.5. Business Performance
8.15.6. Key Strategic Moves And Developments

8.16. Intellia Therapeutics Inc.

8.16.1. Company Overview
8.16.2. Company Snapshot
8.16.3. Operating Business Segments
8.16.4. Product Portfolio
8.16.5. Business Performance
8.16.6. Key Strategic Moves And Developments

8.17. Merck & Co., Inc.

8.17.1. Company Overview
8.17.2. Company Snapshot
8.17.3. Operating Business Segments
8.17.4. Product Portfolio
8.17.5. Business Performance
8.17.6. Key Strategic Moves And Developments

8.18. Novartis Ag

8.18.1. Company Overview
8.18.2. Company Snapshot
8.18.3. Operating Business Segments
8.18.4. Product Portfolio
8.18.5. Business Performance
8.18.6. Key Strategic Moves And Developments

8.19. Regenxbio, Inc.

8.19.1. Company Overview
8.19.2. Company Snapshot
8.19.3. Product Portfolio
8.19.4. Business Performance
8.19.5. Key Strategic Moves And Developments

8.20. Spark Therapeutics, Inc.

8.20.1. Company Overview
8.20.2. Company Snapshot
8.20.3. Operating Business Segments
8.20.4. Product Portfolio
8.20.5. Business Performance
8.20.6. Key Strategic Moves And Developments

8.21. Sangamo Therapeutics, Inc.

8.21.1. Company Overview
8.21.2. Company Snapshot
8.21.3. Operating Business Segments
8.21.4. Product Portfolio
8.21.5. Business Performance
8.21.6. Key Strategic Moves And Developments

8.22. Uniqure N. V.

8.22.1. Company Overview
8.22.2. Company Snapshot
8.22.3. Operation Segments
8.22.4. Product Portfolio
8.22.5. Business Performance
8.22.6. Key Strategic Moves And Developments

8.23. Voyager Therapeutics, Inc.

8.23.1. Company Overview
8.23.2. Company Snapshot
8.23.3. Operating Business Segments
8.23.4. Product Portfolio
8.23.5. Business Performance
8.23.6. Key Strategic Moves And Developments


【レポート販売概要】

■ タイトル:遺伝子治療の世界市場:ベクター種類別(ウイルスベクター、非ウイルスベクター)、遺伝子種類別(抗原、サイトカイン、腫瘍抑制因子、自殺、欠乏、成長因子、受容体、その他)、用途別(腫瘍性疾患、希少疾患、心血管疾患、神経疾患、感染症、その他)
■ 英文:Gene Therapy Market by Vector Type (Viral Vector and Non-viral Vector), Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors, and Others), and Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Other Diseases): Global Opportunity Analysis and Industry Forecast, 2019–2026


■ 発行日:2019年12月31日
■ 調査会社:Allied Market Research
■ 商品コード:AMR20FE041
■ 調査対象地域:グローバル
  • 眼科レーザの世界市場2016-2020
    About the Ophthalmic Lasers Market Medical laser systems are used in various therapeutic areas such as dermatology, ophthalmology, gynecology, and urology. The introduction of a wide range of surgical and aesthetic treatments has led surgeons to perform various medical laser procedures. Advances in medical laser technology have led vendors to develop cost-effective photonic solutions, including be …
  • イギリスの心臓律動管理(CRM)装置市場見通し
    United Kingdom Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 Summary GlobalData’s new report, "United Kingdom Cardiac Rhythm Management (CRM) Procedures Outlook to 2021", provides key procedures data on the United Kingdom Cardiac Rhythm Management (CRM) Procedures. The report provides procedure volumes within market segments - Implantable Loop Recorder (ILR) Procedures, Cardiac Resync …
  • 集束剤及び増粘剤の世界市場
    The global sizing & thickening agents market is dominated by North America and Europe. Developing countries are the leading exporters of sizing & thickening agents to North America and Europe. European and Middle Eastern countries have been increasing their production of sizing & thickening agents. The market in the Asia-Pacific region is projected to grow at a CAGR of 6.5% from 2015 to 2020. The …
  • 世界の大型トラック市場動向
    This latest just-auto report edition offers a global review of the heavy trucks sector, its manufacturers, top markets, technologies and market forecasts. This global market study offers: Heavy trucks market size estimates Latest technologies and trends Manufacturer production and sales volumes and forecasts Profiles of the major players including their strategies and prospects Market size forecas …
  • ゴム加工装置の世界市場2016-2020
    About the Rubber Processing Equipment Market Rubber processing equipment is used to process raw rubber. Processing methodologies include mastication and other methods like mixing, extrusion, and calendering. These processes give shape to the final product. The mastication processing method breaks down the polymer chains to reduce the molecular mass and increase viscosity. This aids in further proc …
  • アルギン酸及びアルギン酸誘導体の世界市場:アルギン酸ナトリウム、アルギン酸カルシウム、アルギン酸カリウム、PGA
    The market for alginates & derivatives is observed to be growing at a modest rate in developed economies such as Europe and North America as compared to developing regions due to the matured industrial sector in the former. The textile and food & beverage industries are still major consumers of alginates and this consumption is expected to grow at a healthy rate. As alginates act as natural bindin …
  • 高等教育モバイルラーニングの世界市場2015-2019
    About M-Learning Products and Services M-learning provides education-related content on smartphones and tablets. Education-related content refers to all the digital learning content available on personal devices. M-learning service providers deliver learning solutions through latest tools and technology, which impart users with rich media and graphics-based learning. This method of learning is cos …
  • 水素生成の世界市場予測(~2022年)
    The global hydrogen generation market is projected to grow at a CAGR of 6.07%, from 2017 to 2022, to reach a market size of USD 154.74 Billion by 2022. This growth is attributed to government regulations for the desulfurization of petroleum products and a rising demand for hydrogen as a transportation fuel. The report segments the hydrogen generation market, by generation type, into captive and me …
  • 世界のスマート・ファクトリ市場:SCADA, DCS, PLC, ERP, MES, PLM, MOM
    The Smart Factory is referred to as a fully integrated and affordable factory automation solution that streamlines the flow of materials through a manufacturing facility. Most of the industry experts believe that the smart factory will be the next big fixation in the industrial revolution. It offers MES and factory specific templates, enables problem visibility, and delivers factory reports and da …
  • インドの農業の機械化市場2016-2020
    About Farm Mechanization The global farm mechanization market is largely dependent on agricultural land and farm output. Global agricultural production affects the market substantially as it grows in tandem with the demand for food. However, in various phases, the global agricultural production has slowed down in recent years as the demand for agricultural products has decreased. Recent environmen …
  • ヨット用バッテリーの世界市場2017-2021
    About Yacht BatteryYachts are recreational boats designed with luxury amenities, and are purchased by individuals belonging to the high-income group. Yachts with a length greater than 24 feet are known as luxury yachts, superyachts, mega yachts, or large yachts. They are segmented based on size and propulsion, and are largely used for recreational purposes. The global yacht battery market is mainl …
  • テレビの世界市場2017-2021:2Dテレビ、3Dテレビ
    ABSTRACTAbout TV The global TV market has observed a shift from bulky CRT TVs to flat panel LCD and OLED TVs over the past decade. Consumer are preferring large-screen TVs as they have become a status symbol nowadays. It is expected that TVs with display size ranging between 50 and 59 inch will have the fastest adoption rate during the forecast period. This is because larger screens provide better …
  • Gas Natural Fenosa:石油・ガスバリューチェーン分析レポート2013
    Gas Natural Fenosa Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Gas Natural Fenosa" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Gas Natural Fenosa”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines t …
  • ポリフッ化ビニリデン(PVDF)のグローバル市場動向(~2019)
    The report covers the global PVDF market. It further divides the market on the basis of end user industry, applications, geography. The market data for these types is given with respect to volume (metric tons) and value ($thousand). The global market value of PVDF was estimated to be $596,009.6 thousand in 2012 and is projected to grow with a CAGR of about 7.4% from 2014 to 2019. The data mentione …
  • 個人用高級品の世界市場2019-2023
    About this market The influence of different marketing strategies on customers’ purchase decisions will lead the personal luxury goods market to register considerable growth in the forthcoming years. Customers are seeking value for money, especially while buying expensive products. Various luxury brand manufacturers are adopting effective marketing techniques and strategies for expanding their con …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。